| |
| |
|
| Insider
Information: |
Nanavaty Maulik |
| Relationship: |
|
| City: |
Natick |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
177,758 |
|
|
Indirect Shares
|
11,017 |
|
|
| Direct
Value |
$13,232,310 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
188,775 |
|
|
| Total
Value |
$13,232,310 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 6.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Boston Scientific Corp |
BSX |
SVP & Pres, Neuromodul... |
2022-02-28 |
177,258 |
|
0 |
Premium* |
|
|
Rani Therapeutics Holdings, Inc. |
RANI |
|
2023-11-16 |
500 |
2023-11-16 |
11,017 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
176 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-04-15 |
4 |
AS |
$37.81 |
$114,905 |
D/D |
(3,039) |
254,469 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-06-17 |
4 |
AS |
$40.46 |
$122,958 |
D/D |
(3,039) |
254,469 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-06-17 |
4 |
OE |
$7.41 |
$22,519 |
D/D |
3,039 |
257,508 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2017-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,383 |
219,923 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2021-01-01 |
4 |
D |
$35.95 |
$130,319 |
D/D |
(3,625) |
235,159 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-01-01 |
4 |
D |
$35.34 |
$138,992 |
D/D |
(3,933) |
240,168 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2018-01-01 |
4 |
D |
$24.79 |
$100,375 |
D/D |
(4,049) |
214,189 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & President, Neuromodula |
• – – |
2011-10-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,580 |
49,916 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2012-10-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,580 |
66,952 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-02-15 |
4 |
OE |
$0.00 |
$22,519 |
D/D |
4,700 |
244,868 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2018-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,012 |
234,849 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2020-01-03 |
4 |
AS |
$44.73 |
$224,757 |
D/D |
(5,025) |
255,194 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• – – |
2012-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,391 |
53,637 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2013-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,393 |
70,665 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2017-01-01 |
4 |
D |
$21.63 |
$117,797 |
D/D |
(5,446) |
184,300 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2014-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,652 |
103,208 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2015-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,652 |
136,659 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2016-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,653 |
177,689 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2022-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,175 |
173,752 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2015-01-01 |
4 |
D |
$13.25 |
$82,826 |
D/D |
(6,251) |
112,456 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2020-02-14 |
4 |
D |
$42.31 |
$266,553 |
D/D |
(6,300) |
262,334 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2018-02-12 |
4 |
D |
$26.18 |
$166,505 |
D/D |
(6,360) |
226,221 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2013-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,369 |
77,189 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2014-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,369 |
99,951 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2015-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,370 |
133,402 |
0 |
- |
|
176 Records found
|
|
Page 5 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
